Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.
about
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesPharmacogenetic considerations in the treatment of Parkinson's disease.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's diseaseDopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.
P2860
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@en
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@nl
type
label
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@en
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@nl
prefLabel
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@en
Do tardive dyskinesia and L-do ...... factors? An exploratory study.
@nl
P2093
P2860
P50
P1476
Do tardive dyskinesia and L-do ...... factors? An exploratory study
@en
P2093
Bernard Lerer
Gilad Yahalom
Lior Greenbaum
Oren S Cohen
Polina Zozulinsky
Sharon Hassin-Baer
Silvana Tesei
Tzuri Lifschytz
P2860
P2888
P304
P356
10.1007/S12031-013-0020-X
P577
2013-05-12T00:00:00Z
P6179
1007390058